Replay available

Alleima AB (publ) (ALLEI) Q2 2025 Earnings Call

Alleima AB (publ) (STO: ALLEI) Q2 2025 earnings conference call, held 2025-07-18. Replay captured from the company's public earnings webcast.

Fri, July 18, 2025 at 7:00 AMendedReplay
Alleima AB (publ) (ALLEI) Q2 2025 Earnings Call

Hosted by

Featured presenters

Emelie Alm

Head of Investor Relations

Göran Görkman

President and CEO

Olof Bengtsson

CFO

Adrian Gilani

Analyst, ABG

Victor Trollsten

Analyst, Danske Bank

Igor Kubitsch

Analyst, DNB

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Alleima Ab.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.236 Hi everyone and welcome to the presentation of the second quarter 2025 interim 00:00:05.236 -- 00:00:10.661 report for ALERMA. My name is Emelie Alm and I am head of Investor Relations. 00:00:10.661 -- 00:00:16.567 I'm joined by Göran Görkman, president and CEO, and Olof Bengtsson, CFO. 00:00:16.567 -- 00:00:21.552 So as usual, Göran and Olof will take you through the results and then we will have a 00:00:21.552 -- 00:00:26.897 Q&A session. You can ask questions either in the chat, in the webcast or 00:00:26.897 -- 00:00:29.918 on the conference call. 00:00:30.423 -- 00:00:35.590 And as always, safety is our top priority, and we trust 00:00:35.590 -- 00:00:39.135 that you know the safety routines of where you are located. 00:00:39.135 -- 00:00:42.580 So with that, I would like to hand over to you, Jaron. 00:00:42.580 -- 00:00:46.465 Thank you, Emily. Hi, everyone, and thank you for listening. 00:00:46.465 -- 00:00:51.209 So I'll start with the highlights of the quarter. 00:00:51.280 -- 00:00:56.447 Well, I think we're performing okay in a challenging market environment with the 00:00:56.447 -- 00:01:01.815 mixed demand. Our broad exposure reduces volatility, but of course we note a negative 00:01:01.815 -- 00:01:07.343 organic top-line growth. Our order intake rolling 12 declined 2%, and 00:01:07.343 -- 00:01:11.902 revenues in the quarter minus 4% from high comps last year. 00:01:11.902 -- 00:01:17.049 A backlog is still good in important segments such as oil and gas, 00:01:17.049 -- 00:01:22.416 in nuclear and in medical, a good product mix and visibility for the near-term future. 00:01:22.416 -- 00:01:27.843 In the more volume business like industrial segment and in chem, petro, 00:01:27.843 -- 00:01:31.477 in Europe in particul...